Metachronous lesions after gastric endoscopic submucosal dissection: first assessment of the FAMISH prediction score

Abstract

Background Surveillance after gastric endoscopic submucosal dissection (ESD) is recommended for all patients owing to the persistent risk of metachronous gastric lesions (MGLs). We developed and validated a prediction score to estimate MGL risk after ESD for early neoplastic gastric lesions, to define an individualized and cost-saving approach.

Methods Clinical predictors and a risk score were derived from meta-analysis data. A retrospective, single-center, cohort study including patients with ≥ 3 years of standardized surveillance after ESD was conducted for score validation. Predictive accuracy of the score by the area under the receiver operating characteristic curve (AUC) was assessed and cumulative probabilities of MGL were estimated.

Results The risk score (0–9 points) included six clinical predictors (scored 0–3): positive family history of gastric cancer, older age, male sex, corpus intestinal metaplasia, synchronous gastric lesions, and persistent Helicobacter pylori infection (FAMISH). The study population included 263 patients. The MGL rate was 16 %. The score diagnostic accuracy for predicting MGL at 3 years’ follow-up, measured by the AUC, was 0.704 (95 %CI 0.603–0.806). At 3 years and a cutoff < 2, the score achieved maximal sensitivity and negative predictive value; 15 % of patients could be assigned to a low-risk group, in which the progression to MGL was significantly lower than for the high-risk group (P = 0.04).

Conclusion The FAMISH score might be a useful tool to accurately identify patients with low-to-intermediate risk for MGL at 3 years of follow-up who could have surveillance intervals extended to reduce the burden of care.

• References

• 1 Rose T, Pennington A, Kypridemos C. et al. Analysis of the burden and economic impact of digestive diseases and investigation of research gaps and priorities in the field of digestive health in the European region – White Book 2: executive summary. United European Gastroenterol J 2022; 10: 657-662
• 2 Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-854
• 3 Prinz F, Ebigbo A, Probst A. et al. Gastric cancer – endoscopic treatment of early lesions, the West learns from the East. Best Pract Res Clin Gastroenterol 2021; 50–51: 101739
• 4 Ortigão R, Figueirôa G, Frazzoni L. et al. Risk factors for gastric metachronous lesions after endoscopic or surgical resection: a systematic review and meta-analysis. Endoscopy 2022; 54: 892-901
• 5 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ. et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022. Endoscopy 2022; 54: 591-622
• 6 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 2021; 24: 1-21
• 7 Ono H, Yao K, Fujishiro M. et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc 2021; 33: 4-20
• 8 Libânio D, Pimentel-Nunes P, Afonso LP. et al. Long-term outcomes of gastric endoscopic submucosal dissection: focus on metachronous and non-curative resection management. GE Port J Gastroenterol 2017; 24: 31-39
• 9 Pimentel-Nunes P, Mourão F, Veloso N. et al. Long-term follow-up after endoscopic resection of gastric superficial neoplastic lesions in Portugal. Endoscopy 2014; 46: 933-940
• 10 Abe S, Oda I, Minagawa T. et al. Metachronous gastric cancer following curative endoscopic resection of early gastric cancer. Clin Endosc 2018; 51: 253-259
• 11 Suzuki H, Takizawa K, Hirasawa T. et al. Short-term outcomes of multicenter prospective cohort study of gastric endoscopic resection: ‘Real-world evidence’ in Japan. Dig Endosc 2019; 31: 30-39
• 12 Tanabe S, Ishido K, Matsumoto T. et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study. Gastric Cancer 2017; 20: 45-52
• 13 Libânio D, Braga V, Ferraz S. et al. Prospective comparative study of endoscopic submucosal dissection and gastrectomy for early neoplastic lesions including patients’ perspectives. Endoscopy 2019; 51: 30-39
• 14 Abe S, Oda I, Suzuki H. et al. Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection. Endoscopy 2015; 47: 1113-1118
• 15 Kobayashi M, Narisawa R, Sato Y. et al. Self-limiting risk of metachronous gastric cancers after endoscopic resection. Dig Endosc 2010; 22: 169-173
• 16 Figueiroa G, Pimentel-Nunes P, Dinis-Ribeiro M. et al. Gastric endoscopic submucosal dissection: a systematic review and meta-analysis on risk factors for poor short-term outcomes. Eur J Gastroenterol Hepatol 2019; 31: 1234-1246
• 17 Xu SS, Chai NL, Tang XW. et al. Characteristics of metachronous gastric neoplasms after curative endoscopic submucosal dissection for early gastric neoplasms. Chin Med J (Engl) 2021; 134: 2603-2610
• 18 Nakajima T, Oda I, Gotoda T. et al. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance?. Gastric Cancer 2006; 9: 93-98
• 19 Wang AY, Hwang JH, Bhatt A. et al. AGA clinical practice update on surveillance after pathologically curative endoscopic submucosal dissection of early gastrointestinal neoplasia in the United States: commentary. Gastroenterology 2021; 161: 2030-2040
• 20 Kato M, Nishida T, Yamamoto K. et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut 2013; 62: 1425-1432
• 21 Watari J, Tomita T, Tozawa K. et al. Preventing metachronous gastric cancer after the endoscopic resection of gastric epithelial neoplasia: roles of Helicobacter pylori eradication and aspirin. Gut Liver 2020; 14: 281-290
• 22 Chung CS, Woo HS, Chung JW. et al. Risk factors for metachronous recurrence after endoscopic submucosal dissection of early gastric cancer. J Korean Med Sci 2017; 32: 421-426
• 23 Nozaki I, Nasu J, Kubo Y. et al. Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg 2010; 34: 1548-1554
• 24 Morgagni P, Gardini A, Marrelli D. et al. Gastric stump carcinoma after distal subtotal gastrectomy for early gastric cancer: experience of 541 patients with long-term follow-up. Am J Surg 2015; 209: 1063-1068
• 25 Collins GS, Reitsma JB, Altman DG. et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 2015; 350: g7594
• 26 Moons KG, Kengne AP, Woodward M. et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 2012; 98: 683-690
• 27 Moons KG, Altman DG, Reitsma JB. et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 2015; 162: W1-73
• 28 Solomon DH, Ganz DA, Avorn J. et al. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. J Clin Epidemiol 2002; 55: 121-128
• 29 Esposito G, Pimentel-Nunes P, Angeletti S. et al. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study. Endoscopy 2019; 51: 515-521
• 30 Unal I. Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med 2017; 2017: 3762651
• 31 Yoon H, Kim N, Shin CM. et al. Risk factors for metachronous gastric neoplasms in patients who underwent endoscopic resection of a gastric neoplasm. Gut Liver 2016; 10: 228-236
• 32 Kim HJ, Kim YJ, Seo SI. et al. Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study. Gastrointest Endosc 2020; 92: 613-622
• 33 Brito-Gonçalves G, Libânio D, Marcos P. et al. Clinicopathologic characteristics of patients with gastric superficial neoplasia and risk factors for multiple lesions after endoscopic submucosal dissection in a Western country. GE Port J Gastroenterol 2020; 27: 76-89
• 34 Zhou HJ, Dan YY, Naidoo N. et al. A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk. PLoS One 2013; 8: e83959
• 35 Yeh JM, Hur C, Ward Z. et al. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut 2016; 65: 563-574